Blood pressure lowering effect of renal sympathetic denervation or placebo? - Building expectations for Symplicity-HTN 3

Blood Pressure

Volumn 22, Issue 5, 2013, Pages 279-281

  Kjeldsen, Sverre E ^a   Narkiewicz, Krzysztof ^b   Oparil, Suzanne ^c   Hedner, Thomas ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; PLACEBO;

ANTIHYPERTENSIVE THERAPY; AUTONOMIC DENERVATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; ESSENTIAL HYPERTENSION; FOLLOW UP; HUMAN; HYPERTENSION; IMPEDANCE CARDIOGRAPHY; KIDNEY DENERVATION; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; MEDICATION COMPLIANCE; PATIENT REFERRAL; PRIORITY JOURNAL; RENAL SYMPATHETIC DENERVATION; RESISTANT HYPERTENSION; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; URINALYSIS; WHITE COAT HYPERTENSION;

BLOOD PRESSURE; HUMANS; HYPERTENSION; KIDNEY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SYMPATHECTOMY;

EID: 84884681597     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2013.840445     Document Type: Editorial

References (14)

1. De La Sierra A, Segura J, Banegas J R, Gorostidi M, De La Cruz JJ, Armario P, Oliveras A, Ruilope LM. Clinical features of 8295 patients with resistant hypertension classifi ed on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57: 889-890
2. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension. Novel implications for an old concept. Hypertension 2009; 54: 1195-1201
3. Verloop WL, Vink EE, Voskuil M, Vonken EJ, Rookmaaker MB, Bots ML, Doevendans PA, Blankestijn PJ, Spiering W. Eligibility for percutaneous renal denervation: The importance of a systematic screening. J Hypertens 2013; 31: 1662-8. doi: 10.1097/HJH.0b013e328362152e. PubMed PMID: 23743806
4. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. Lancet 2010; 376: 1903-1909
5. Gifford RW. A n algorithm for the management of resistant hypertension. Hypertension 1988; 11: I171-175
6. Klein LE. C ompliance and blood pressure control. Hypertension 1988; 11: I161-164
7. Ceral J, Habrdova V, Vorisek V, Bima M, Pelouch R, Solar M. Diffi cult-To-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from nonadherence to recommended therapy. Hypertens Res 2011; 34: 87-90
8. K andzari DE, Bhatt DL, Sobotka PA, O 'Neill WW, Esler M, Flack JM, Katzen BT, Leon MB, Massaro JM, Negoita M, Oparil S, Rocha-Singh K, Straley C, Townsend RR, Bakris G. Catheter-based renal denervation for resistant hypertension: Rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol 2012; 35: 528-535
9. Brinkmann J, Heusser K, Schmidt B M, Menne J, Klein G, Bauersachs J, Haller H, Sweep FC, Diedrich A, Jordan J, Tank J. Catheter-based renal nerve ablation and centrally generated sympathetic activity in diffi cult-To-control hypertensive patients: Prospective case series. Hypertension 2012; 60: 1485-1490
10. Fadl-Elmula FEM, Hoffmann P, Fossum E, Brekke M, Gjønn æ ss E, Hjørnholm U, Kj æ r VN, Rostrup M, Kjeldsen SE, Os I, Stenehjem AE, Hø ieggen A. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure. Hypertension 2013; 62: 526-532
11. Savard S, Frank M, Bobrie G, Plouin P -F, Sapoval M, Azizi M. Eligibility for renal denervation in patients with resistant hypertension: When enthusiasm meets reality in real-life patients. J Am Coll Cardiol 2012; 60: 2422-2424
12. Persu A, Jin Y, Azizi M, Baelen M, Völ z S, Elvan A, Severino F, Rosa J, Adiyaman A, Fadl-Elmula FEM, Taylor A, Pechè re-Bertschi A, Wuerzner G, Jokhaji F, Kahan T, Renkin J, Monge M, Widimsk ý P, Jacobs L, Burnier M, Mark PB, Kjeldsen SE, Andersson B, Sapoval M, Staessen JA on behalf of the European Network Coordinating research on REnal denervation (ENCOReD). Blood Pressure Changes after Renal Denervation at 10 European Expert Centers. J Human Hypertens 2013, in press
13. Taler S J, Textor S C, Augustine J E. Resistant hypertension: Comparing hemodynamic management to specialist care. Hypertension 2002; 39: 982-988
14. Stenehjem A E, Os I. Reproducibility of blood pressure variability, white-coat effect and dipping pattern in untreated, uncomplicated and newly diagnoseDessential hypertension. Blood Press 2004; 13: 214-224.